Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A 54-week, Multi-centre, 2-arm, Randomised Controlled Trial to Assess Home Monitoring for Lung Function and Patient Reported Outcome Measurements Vs. Usual Care in RheuMatic Disease-associated Interstitial Lung Disease: the RMD-mILDer Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06732674
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:02.128598+00:00
Published At
2024-12-19T00:00:00+00:00
Record Updated At
2024-12-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere", "Systemic Sclerosis Pulmonary", "Dermatomyositis", "Rheumatoid Arthritis", "Sjogren Syndrome with Lung Involvement", "Connective Tissue Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-19"
protocolSection.identificationModule.nctId
"NCT06732674"
protocolSection.identificationModule.officialTitle
"A 54-week, Multi-centre, 2-arm, Randomised Controlled Trial to Assess Home Monitoring for Lung Function and Patient Reported Outcome Measurements Vs. Usual Care in RheuMatic Disease-associated Interstitial Lung Disease: the RMD-mILDer Trial"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere (protocolSection.conditionsModule.conditions)
  • Systemic Sclerosis Pulmonary (protocolSection.conditionsModule.conditions)
  • Dermatomyositis (protocolSection.conditionsModule.conditions)
  • Rheumatoid Arthritis (protocolSection.conditionsModule.conditions)
  • Sjogren Syndrome with Lung Involvement (protocolSection.conditionsModule.conditions)
  • Connective Tissue Diseases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.